| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $5,138,534 ) |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HL153895 | The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery | 000 | 3 | NIH | 12/15/2023 | $167,863 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01AI147778 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response | 000 | 5 | NIH | 11/17/2023 | $588,304 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 7 | HRSA | 12/6/2023 | $211,894 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 7 | HRSA | 12/6/2023 | $461,005 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $92,128 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $200,437 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $419,182 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $911,987 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01DK139363 | Addressing social determinants of health in child obesity treatment using community health workers: the role of parental bandwidth in treatment effectiveness - feasibility study for full - scale RCT | 000 | 1 | NIH | 3/5/2024 | $289,712 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R34MH132473 | Enhancing communication on relationship preservation, safer conception and PrEP to promote HIV testing | 001 | 2 | NIH | 11/7/2023 | -$182,279 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R34MH132473 | Enhancing communication on relationship preservation, safer conception and PrEP to promote HIV testing | 000 | 2 | NIH | 11/6/2023 | $182,279 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R34MH132473 | Enhancing communication on relationship preservation, safer conception and PrEP to promote HIV testing | 001 | 2 | NIH | 11/7/2023 | $182,279 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD110447 | Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects | 000 | 2 | NIH | 11/29/2023 | $592,525 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23DA055736 | Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital | 000 | 3 | NIH | 4/17/2024 | $189,540 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HD098299 | Promoting Healthy Relationships among At-Risk Adolescents: A Feasibility Trial in the Emergency Department | 000 | 5 | NIH | 2/29/2024 | $157,950 |
| 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HL162937 | DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD) | 000 | 2 | NIH | 1/29/2024 | $515,432 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23DK115827 | Effect of Obesity on Pantoprazole Pharmacokinetics and Pharmacodynamics in Children | 000 | 4 | NIH | 11/1/2023 | -$116,324 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 05 | 6 | HRSA | 2/9/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 05 | 6 | HRSA | 2/9/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 05 | 6 | HRSA | 2/9/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T32HD069038 | Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology | 000 | 13 | NIH | 1/5/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R00HD107262 | Regulation of Invasive Trophoblast Cell Lineage Development | 000 | 3 | NIH | 2/26/2024 | $4,628 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA279065 | Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer | 001 | 2 | NIH | 3/12/2024 | $269,992 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01GM129783 | Trimethoprim: an overlooked contributor of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions | 000 | 5 | NIH | 3/18/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 3 | CDC | 2/27/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21HD098086 | Multi-level Emergency Department Intervention to Reduce Pregnancy Risk Among Adolescents | 000 | 2 | NIH | 4/4/2024 | $0 |
| 2024 | 2021 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21HD101111 | Less Lumping, Smarter Splitting: Genomics and Metabolomics of Systemic Steroid Response in Bronchopulmonary Dysplasia | 000 | 2 | NIH | 2/27/2024 | $0 |
| 2024 | 2020 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | P50HD090258 | Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids | 000 | 5 | NIH | 2/8/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $19,035,583 ) (Continued on the next page) |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21HG012422 | Novel computational approaches to characterize the effects of rare functional outlier variants on cis- and trans-regulatory disease processes | 000 | 2 | NIH | 7/24/2023 | $234,000 |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 3 | CDC | 8/23/2023 | $78,857 |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 3 | CDC | 8/23/2023 | $1,549,740 |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 3 | CDC | 8/23/2023 | $621,400 |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 3 | CDC | 8/23/2023 | $499,999 |
| 2023 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K08DK125735 | Gene-environment interactions in necrotizing enterocolitis: impact of SIGIRR mutation and gut microbiota on intestinal TLR hyperactivity | 000 | 4 | NIH | 7/7/2023 | $162,396 |
|